FSD1
Fibronectin type III and SPRY domain-containing protein 1
Also known as: FSD1_HUMAN, MGC3213, MIR1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BTV5
- Gene
- FSD1
- Ensembl
- ENSG00000105255
- Chromosome
- 19
- Canonical length
- 496 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a centrosome associated protein that is characterized by an N-terminal coiled-coil region downstream of B-box (BBC) domain, a central fibronectin type III domain, and a C-terminal repeats in splA and RyR (SPRY) domain. The encoded protein associates with a subset of microtubules and may be involved in the stability and organization of microtubules during cytokinesis. [provided by RefSeq, Apr 2009]
Canonical amino-acid sequenceUniProt
496 residues, UniProt reviewed canonical sequence.
>Q9BTV5|FSD1
1 MEEQREALRK IIKTLAVKNE EIQSFIYSLK QMLLNVEANS AKVQEDLEAE FQSLFSLLEE
61 LKEGMLMKIK QDRASRTYEL QNQLAACTRA LESSEELLET ANQTLQAMDS EDFPQAAKQI
121 KDGVTMAPAF RLSLKAKVSD NMSHLMVDFA QERQMLQALK FLPVPSAPVI DLAESLVADN
181 CVTLVWRMPD EDSKIDHYVL EYRRTNFEGP PRLKEDQPWM VIEGIRQTEY TLTGLKFDMK
241 YMNFRVKACN KAVAGEFSEP VTLETPAFMF RLDASTSHQN LRVDDLSVEW DAMGGKVQDI
301 KAREKDGKGR TASPINSPAR GTPSPKRMPS GRGGRDRFTA ESYTVLGDTL IDGGEHYWEV
361 RYEPDSKAFG VGVAYRSLGR FEQLGKTAAS WCLHVNNWLQ VSFTAKHANK VKVLDAPVPD
421 CLGVHCDFHQ GLLSFYNART KQVLHTFKTR FTQPLLPAFT VWCGSFQVTT GLQVPSAVRC
481 LQKRGSATSS SNTSLTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FSD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 35 nTPM
- hippocampal formation: 24 nTPM
- hypothalamus: 22 nTPM
- amygdala: 21 nTPM
- cerebellum: 20 nTPM
- midbrain: 15 nTPM
Single-cell type
- undifferentiated spermatogonia: 48 nCPM
- brain excitatory neurons: 33 nCPM
- other brain neurons: 31 nCPM
- brain inhibitory neurons: 27 nCPM
- innate lymphoid cells: 27 nCPM
- nk-cells: 25 nCPM
Immune cell
- NK-cell: 5.4 nTPM
- MAIT T-cell: 3.6 nTPM
- plasmacytoid DC: 1.4 nTPM
- naive CD4 T-cell: 0.7 nTPM
- total PBMC: 0.7 nTPM
- gdT-cell: 0.5 nTPM
Brain region
- pons: 30 nTPM
- thalamus: 30 nTPM
- cerebral cortex: 29 nTPM
- hippocampal formation: 26 nTPM
- medulla oblongata: 23 nTPM
- hypothalamus: 22 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.47
- gnomAD pLI
- 0.25
- gnomAD missense Z
- 1.24
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell division
- cytoplasmic microtubule organization
- regulation of cell division
- regulation of cytokinesis
- regulation of mitotic spindle organization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- B30.2/SPRY domain
- B-box, C-terminal
- SPRY domain
- Fibronectin type III
- Concanavalin A-like lectin/glucanase domain superfamily
- Immunoglobulin-like fold
- COS domain
- Fibronectin type III and SPRY containing 1, PRY/SPRY domain
- Fibronectin type III superfamily
- B30.2/SPRY domain superfamily
- E3 ubiquitin-protein ligases and FN3/SPRY domain-containing proteins
- Fibronectin type III domain
- SPRY domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FSD1 as an antibody target. Whether an autoantibody or antibody against FSD1 could matter depends on whether native FSD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FSD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FSD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...